Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaquesReport as inadecuate




Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques - Download this document for free, or read online. Document in PDF available to download.

Reference: Borthwick, Nicola J., Rosario, M, Schiffner, T et al., (2015). Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques. Immunity, Inflammation and Disease, 3 (2), 82-93.Citable link to this page:

 

Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques

Abstract: Vaccines delivering T cell immunogen HIVconsv vectored by plasmid DNA, non-replicating simian adenovirus and non-replicating modified vaccinia virus Ankara (MVA) are under clinical evaluation in phase I/IIa trials in UK, Europe, and Africa. While these vaccines aim to induce effector T cell responses specific for HIV-1, we here characterized the humoral responses induced by HIVconsv administration to macaques using six different vaccine modalities: plasmid DNA, human adenovirus serotype 5, simian adenovirus serotype 63, MVA, Semliki Forest virus replicons, and adjuvanted overlapping synthetic long peptides (SLP). We found that only the SLP formulation, but none of the genetic vaccine platforms induced antibodies recognizing linear HIVconsv epitopes, median 32/46 SLP.HIVconsv peptides. These antibodies bound to 15-mer and SLP peptides, recombinant gp120 and trimeric gp140 of HIV-1 Bal, YU2, JRFL, and UG037, but failed to react with HIV-1 Bal and IIIB virions and HIV-1 Bal- and IIIB-infected human cells, and consequently failed to induce neutralizing antibodies. The HIVconsv immunogen contains conserved regions derived from Gag, Pol, Vif, and Env proteins of HIV-1, and antibodies induced by the SLP.HIVconsv vaccination resulted in positive signals in routine HIV-1 tests. Thus, only HIVconsv delivered by SLP resulted in seroconversion, an observation that provides important guidance for recruiting volunteers into future clinical trials. Furthermore, our data confirms that vaccine delivery by SLP induces humoral as well as cellular immune responses and could be considered for inclusion in future vaccine regimens where this is required.

Peer Review status:Peer ReviewedPublication status:Published Funder: Medical Research Council   Funder: Department for International Development   Notes:This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Bibliographic Details

Publisher: John Wiley and Sons, Inc.

Publisher Website: http://onlinelibrary.wiley.com/

Journal: Immunity, Inflammation and Diseasesee more from them

Publication Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-4527

Issue Date: 2015-6

pages:82-93Identifiers

Urn: uuid:fc15a023-d024-4537-a010-dc7ae509bc9c

Source identifier: 525725

Doi: https://doi.org/10.1002/iid3.52

Issn: 2050-4527 Item Description

Type: Journal article; Keywords: antibodies conserved regions HIV vaccines macaques synthetic long peptides Tiny URL: pubs:525725

Relationships





Author: Borthwick, Nicola J. - institutionUniversity of Oxford The Jenner Institute - - - Rosario, M - - - Schiffner, T - institutionUniv

Source: https://ora.ox.ac.uk/objects/uuid:fc15a023-d024-4537-a010-dc7ae509bc9c



DOWNLOAD PDF




Related documents